scispace - formally typeset
M

Morgan L. Truitt

Researcher at University of California, San Francisco

Publications -  19
Citations -  6247

Morgan L. Truitt is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: EIF4E & Carcinogenesis. The author has an hindex of 16, co-authored 18 publications receiving 5371 citations. Previous affiliations of Morgan L. Truitt include Brigham and Women's Hospital.

Papers
More filters
Journal ArticleDOI

Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner

TL;DR: It is shown that normal dermal fibroblasts can be "educated" by carcinoma cells to express proinflammatory genes, and this ability to "educate" them is shown to be related to tumor-enhancing inflammation.
Journal ArticleDOI

IRE1α Cleaves Select microRNAs During ER Stress to Derepress Translation of Proapoptotic Caspase-2

TL;DR: It is reported that sustained IRE1α RNase activation caused rapid decay of select microRNAs that normally repress translation of Caspase-2 mRNA, and thus sharply elevates protein levels of this initiator protease of the mitochondrial apoptotic pathway.
Journal ArticleDOI

Autism-related deficits via dysregulated eIF4E-dependent translational control

TL;DR: This article showed that deletion of the eukaryotic translation initiation factor 4E-binding protein 2 (4E-BP2) led to an increased ratio of excitatory to inhibitory synaptic inputs and autistic-like behaviors (that is, social interaction deficits, altered communication and repetitive/stereotyped behaviours).
Journal ArticleDOI

GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation

TL;DR: It is reported that multistage development of PDAC tumors is not affected by the deletion of Smo in the pancreas, demonstrating that autocrine Shh-Ptch-Smo signaling is not required in pancreatic ductal cells for PDAC progression.